跳至主要内容
临床试验/NCT01636258
NCT01636258已完成不适用

Diet, Exercise, Cooking, and Stress Management for Patients With Prediabetes: A Pilot Randomized Controlled Study

The Cleveland Clinic2 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2012年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
27
试验地点
2
主要终点
Effect of "FRESH" Program on Weight Loss

研究概览

简要总结

To examine whether a lifestyle program results in weight loss and thereby delays or prevents progression of pre-diabetes to diabetes, we propose a pilot randomized controlled trial of 6 weeks duration with 30 participants held at Stephanie Tubbs Jones Health Center. Participants are randomized to receive all of the following: nutrition education, exercise instruction, stress management instruction, and culinary education or follow usual care. Outcomes include: blood sugars and cholesterol, weight, waist circumference, blood pressure, diet, physical activity, perceived stress, and class attendance. Analysis is by Intention to treat analysis of variance. Results will be used to help design larger randomized trial in the future.

详细描述

Control group:

These participants will continue to receive their usual care from their primary medical care team.

Intervention group:

The participants will receive nutrition education, exercise instruction, stress management instruction,and culinary education

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Study participants must:
  • Be capable of giving informed consent
  • Understand and voluntarily sign the informed consent form.
  • Be females at least 18 years of age and identify themselves as African-American
  • Have prediabetes as defined by the American Diabetes Association: history of glycated hemoglobin (HgbA1c) 5.7-6.4 % or fasting blood glucose 100-125 mg/dL (5.6-6.9 mmol/L) (fasting defined as no caloric intake for at least 8 hours), or a 2-hour plasma glucose 140-199 mg/dL (7.8-11.0 mmol/L) during an oral glucose tolerance test (as described by the World Health Organization using a glucose load of 75 g anhydrous glucose dissolved in water)
  • Have a body mass index (BMI, defined as weight in kilograms divided by height in meters squared) greater than or equal to 25

排除标准

  • Current or previous diagnosis of diabetes or a history of HgbA1c ≥ 6.5% or fasting blood glucose ≥ 126 mg/dL (7.0 mmol/L) (fasting defined as no caloric intake for at least 8 hours), or a 2-hour plasma glucose ≥ 200 mg/dL (11.1 mmol/L) during an oral glucose tolerance test or a history of classic symptoms of hyperglycemia or hyperglycemic crisis and a random plasma glucose ≥ 200 mg/dL (11.1 mmol/L).
  • Normal glycemia or a currently with a HgbA1c < 5.7% or fasting blood glucose < 100 mg/dL (7.0 mmol/L) (fasting defined as no caloric intake for at least 8 hours), or a 2-hour plasma glucose < 140 mg/dL (11.1 mmol/L) during an oral glucose tolerance test
  • Current or past use of oral hypoglycemic agents (including, but not limited to, metformin, rosiglitazone, pioglitazone, glipizide, and glyburide) or insulin
  • Male gender
  • History of congestive heart failure
  • History of renal failure, dialysis, or creatinine greater than 2 mg/dL
  • History of liver failure or a liver dysfunction with a increase by a factor of 2 above the upper limit of normal in alanine aminotransferase or aspartate aminotransferase
  • History of gastrointestinal disorder that would prevent adherence to the recommended diet (e.g. celiac disease, inflammatory bowel disease, history of bariatric surgery, history of intestinal surgery)
  • Presence of active cancer
  • History of coronary artery disease or cerebrovascular disease
  • History of uncontrolled hypertension
  • Participation in another lifestyle modification trial
  • Pregnancy or lactating or planning to be pregnant
  • Current alcoholism or abuse of recreational drugs
  • Hospitalization for depression in past 12 months
  • Travel plans that do not permit full participation or participant lives too far from Health Center to permit full participation
  • History of bariatric surgery, small bowel resection, or extensive bowel resection
  • Chronic treatment with systemic steroids
  • Current diagnosis of schizophrenia, other psychotic disorders, or bipolar disorder
  • Inability to walk two blocks
  • Other medial, psychiatric, or behavioral limitations that in the judgment of the principal investigator may interfere with study participation or the ability to follow the intervention protocol
  • Amputation of lower limb for nontraumatic causes
  • Self report of HIV-positivity or active tuberculosis
  • Documented history of pulmonary embolus in past six months
  • Chronic obstructive pulmonary disease that would limit ability to follow the study protocol
  • Self-reported chronic hepatitis B or C or cirrhosis; inflammatory bowel disease requiring treatment in past year; Cushing's syndrome; acromegaly (clinical diagnosis or self-report); any major organ transplant
  • Unwilling or uninterested in participating in group lifestyle education sessions
  • Current regular corticosteroid use
  • Active polycystic ovarian syndrome

结局指标

主要结局

Effect of "FRESH" Program on Weight Loss

时间窗: Baseline line and final followup visit (at 8-14 weeks)

Change in weight measured at baseline and followup (at 8-14 weeks).

次要结局

  • Diet - Daily Calorie Intake(Baseline and final followup visit (at 8-14 weeks))
  • Stress(baseline and followup visit (at 8-14 weeks))
  • Sleep(baseline and followup visit (at 8-14 weeks))
  • Exercise(Baseline and final followup visits (at 8-14 weeks))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Linda Libertini

Research Coordinator

The Cleveland Clinic

研究点 (2)

Loading locations...

相似试验

FRESH Study (Fitness, Relaxation and Eating to Stay... | 临床试验